Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans L Tillmann

Showing results (71-80 of 127) with videos related to

Pageof 13
Sort By:
Transplantation|January 2, 2004
Donor origin of de novo hepatocellular carcinoma in hepatic allograftsPeer Flemming, Hans L Tillmann, Hannelore Barg-Hock, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|April 4, 2002
Autoimmunity and HCV infection in porphyria cutanea tarda: a controlled studyUlrich Stölzel, Detlef Schuppan, Hans L Tillmann, et al.
Journal of Gastroenterology and Hepatology|August 18, 2005
Hepatocellular carcinoma and octreotide: treatment results in prospectively assigned patients with advanced tumor and cirrhosis stageRuben R Plentz, Hans L Tillmann, Stefan Kubicka, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 26, 2012
Role of GB virus C in HIV-1-infected and hepatitis C virus-infected hemophiliac children and adolescentsSolveig Tenckhoff, Thorsten Kaiser, Fritz Bredeek, et al.
Metabolic Brain Disease|January 9, 2009
Hepatitis C virus infection and the brainKarin Weissenborn, Anita B Tryc, Meike Heeren, et al.
Antiviral Therapy|August 5, 2008
A decline in hepatitis B virus surface antigen (hbsag) predicts clearance, but does not correlate with quantitative hbeag or HBV DNA levelsJohannes Wiegand, Heiner Wedemeyer, Andrea Finger, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 3, 2008
Antibody to hepatitis B surface antigen trough levels and half-lives do not differ after intravenous and intramuscular hepatitis B immunoglobulin administration after liver transplantationNazanin Hooman, Kinan Rifai, Johannes Hadem, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 11, 2008
Prognostic implications of lactate, bilirubin, and etiology in German patients with acute liver failureJohannes Hadem, Penelope Stiefel, Matthias J Bahr, et al.
Journal of Hepatology|October 13, 2006
Hepatitis A virus infection suppresses hepatitis C virus replication and may lead to clearance of HCVKatja Deterding, Björn Tegtmeyer, Markus Cornberg, et al.
The American Journal of Gastroenterology|April 3, 2002
Lamivudine transiently reduces viral load and improves liver function in liver transplant recipients with fibrosing cholestatic hepatitisHans L Tillmann, Christian Trautwein, C Thomas Bock, et al.
Pageof 13

Showing results (71-80 of 127) with videos related to

Sort By:
Pageof 13
Transplantation|January 2, 2004
Donor origin of de novo hepatocellular carcinoma in hepatic allograftsPeer Flemming, Hans L Tillmann, Hannelore Barg-Hock, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|April 4, 2002
Autoimmunity and HCV infection in porphyria cutanea tarda: a controlled studyUlrich Stölzel, Detlef Schuppan, Hans L Tillmann, et al.
Journal of Gastroenterology and Hepatology|August 18, 2005
Hepatocellular carcinoma and octreotide: treatment results in prospectively assigned patients with advanced tumor and cirrhosis stageRuben R Plentz, Hans L Tillmann, Stefan Kubicka, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 26, 2012
Role of GB virus C in HIV-1-infected and hepatitis C virus-infected hemophiliac children and adolescentsSolveig Tenckhoff, Thorsten Kaiser, Fritz Bredeek, et al.
Metabolic Brain Disease|January 9, 2009
Hepatitis C virus infection and the brainKarin Weissenborn, Anita B Tryc, Meike Heeren, et al.
Antiviral Therapy|August 5, 2008
A decline in hepatitis B virus surface antigen (hbsag) predicts clearance, but does not correlate with quantitative hbeag or HBV DNA levelsJohannes Wiegand, Heiner Wedemeyer, Andrea Finger, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 3, 2008
Antibody to hepatitis B surface antigen trough levels and half-lives do not differ after intravenous and intramuscular hepatitis B immunoglobulin administration after liver transplantationNazanin Hooman, Kinan Rifai, Johannes Hadem, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 11, 2008
Prognostic implications of lactate, bilirubin, and etiology in German patients with acute liver failureJohannes Hadem, Penelope Stiefel, Matthias J Bahr, et al.
Journal of Hepatology|October 13, 2006
Hepatitis A virus infection suppresses hepatitis C virus replication and may lead to clearance of HCVKatja Deterding, Björn Tegtmeyer, Markus Cornberg, et al.
The American Journal of Gastroenterology|April 3, 2002
Lamivudine transiently reduces viral load and improves liver function in liver transplant recipients with fibrosing cholestatic hepatitisHans L Tillmann, Christian Trautwein, C Thomas Bock, et al.
Pageof 13